Selbyville, Delaware, June 10, 2020 (GLOBE NEWSWIRE) -- Worldwide tissue diagnostics market garnered revenues worth USD 3.2 billion in the year 2019 and is predicted to record a y-o-y growth rate of 6.5% between 2020 and 2027. Growing geriatric population coupled with escalating healthcare expenditure are major factors driving product demand across the globe.
Rising prevalence of cancer is also fueling the adoption rates of tissue diagnostic systems. In fact, according to IARC (International Agency for Research on Cancer), on an average 17 million new cases and 9.5 million cancer deaths were recorded in the year 2018. The agency further states that the number of cancer cases are expected to reach 27.5 million and record 16.3 million cancer deaths by the year 2040.
For those uninitiated, tissue diagnostics is a technique which involves the removal of tissue from the patient’s body which is then processed, tested as well as analyzed under the microscope to diagnose the disease, if any.
Tissue diagnostics is widely adopted for diagnosis of cancer. This technique is majorly performed by using open biopsy, core biopsy, and needle aspiration cytology. Additionally, advancements in technology pertaining to tissue diagnostic techniques have resulted in accurate and quick identification as well as evaluation of the disease, such as cancer.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2683160/
Increased pervasiveness of the recent COVID-19 infection coupled with shortage of diagnostic kits to test the disease are augmenting the demand for testing and screening devices. This has compelled tissue diagnostics virology suppliers to focus on providing reliable testing kits, which in turn is creating significant growth opportunities for the tissue diagnostics market.
However, budget constraints and high degree of consolidation may act as restraining factors to the overall market growth.
Product Insights
Global tissue diagnostics market been fragmented into various segments such as product type, technology, application scope, end-use, regions, and the competitive arena.
Based on the product type, the market is split into consumables and instruments. In terms of technology type, the tissue diagnostics industry is divided into special staining, digital pathology & workflow management, ISH (In Situ Hybridization), and IHC (Immunohistochemistry).
Elaborating on the application spectrum, the market is bifurcated into NSCLC (non-small cell lung cancer), lymphoma, prostate cancer, gastric cancer, breast cancer, and others. Whereas citing the end-use landscape, the industry is classified into contract research organizations, pharmaceutical companies, non-laboratories, hospitals, and others.
Geographical Landscape
Worldwide tissue diagnostics market is divided into Latin America, North America, Asia-Pacific, Europe, and the Rest of the World. The North America tissue diagnostics market is slated to record momentous growth during the forecast period driven by high occurrence of COVID-19 infections in tandem with technological advancements in gene & immunoassay-based products.
Alternatively, the Asia-Pacific tissue diagnostics industry is expected to generate substantial revenues in the forthcoming years. Factors such as availability of advanced healthcare infrastructure, increased pervasiveness of cancer, and growing population of baby boomers are augmenting the regional demand.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
https://www.marketstudyreport.com/reports/global-tissue-diagnostics-market-size-research
Competitive Analysis
The major companies formulating the competitive landscape of global tissue diagnostics industry are Hologic Inc., Bio-Genex Laboratories, Sakura Finetek Japan Co. Ltd., Merck KGaA, Agilent Technologies, Abbott Technologies, Thermo Fisher Scientific, Danaher Corp., F. Hoffmann-La Roche AG, and Becton, Dickinson & Co. among others.
Global Tissue Diagnostics Market by Product Analysis (Revenue, USD Billion, 2018-2027)
Consumables
Instruments
Global Tissue Diagnostics Market by Technology Type (Revenue, USD Billion, 2018-2027)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Digital Pathology & Workflow Management
Special Staining
Global Tissue Diagnostics Market by Application Scope (Revenue, USD Billion, 2018-2027)
Breast Cancer
Gastric Cancer
Prostate Cancer
Lymphoma
Non-Small Cell Lung Cancer (NSCLC)
Others
Global Tissue Diagnostics Market by End-use Analysis (Revenue, USD Billion, 2018-2027)
Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Others
Global Tissue Diagnostics Market by Regional Contribution (Revenue, USD Billion, 2018-2027)
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
Rest of the World
Global Tissue Diagnostics Market by Competitive Spectrum (Revenue, USD Billion, 2018-2027)
- F. Hoffmann-La Roche AG
- Danaher Corp.
- Thermo Fisher Scientific
- Abbott Laboratories
- Agilent Technologies
- Merck KGaA
- Sakura Finetek Japan Co. Ltd.
- Becton, Dickinson & Co.
- Bio-Genex Laboratories
- Hologic Inc.
Table of Content:
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Tissue Diagnostics Market, by Region, 2018-2027 (USD Billion)
1.2.2. Tissue Diagnostics Market, by Product, 2018-2027 (USD Billion)
1.2.3. Tissue Diagnostics Market, by Technology, 2018-2027 (USD Billion)
1.2.4. Tissue Diagnostics Market, by Application, 2018-2027 (USD Billion)
1.2.5. Tissue Diagnostics Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Tissue Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Tissue Diagnostics Market Dynamics
3.1. Tissue Diagnostics Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Tissue Diagnostics Market Industry Analysis
4.1. Portera??s 5 Force Model
4.2. PEST Analysis
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Tissue Diagnostics Market, by Product
5.1. Market Snapshot
5.2. Global Tissue Diagnostics Market by Product, Performance - Potential Analysis
5.3. Global Tissue Diagnostics Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4. Tissue Diagnostics Market, Sub Segment Analysis
5.4.1. Consumables
5.4.2. Instruments
Chapter 6. Global Tissue Diagnostics Market, by Technology
6.1. Market Snapshot
6.2. Global Tissue Diagnostics Market by Technology, Performance - Potential Analysis
6.3. Global Tissue Diagnostics Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
6.4. Tissue Diagnostics Market, Sub Segment Analysis
6.4.1. Immunohistochemistry (IHC)
6.4.2. In Situ Hybridization (ISH)
6.4.3. Digital Pathology and Workflow Management
6.4.4. Special Staining
Chapter 7. Global Tissue Diagnostics Market, by Application
7.1. Market Snapshot
7.2. Global Tissue Diagnostics Market by Application - Potential Analysis
7.3. Global Tissue Diagnostics Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
7.4. Tissue Diagnostics Market, Sub Segment Analysis
7.4.1. Breast Cancer
7.4.2. Gastric Cancer
7.4.3. Prostate Cancer
7.4.4. Lymphoma
7.4.5. Non-Small Cell Lung Cancer (NSCLC)
7.4.6. Others
Chapter 8. Global Tissue Diagnostics Market, by End-User
8.1. Market Snapshot
8.2. Global Tissue Diagnostics Market by End-User - Potential Analysis
8.3. Global Tissue Diagnostics Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
8.4. Tissue Diagnostics Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Research Laboratories
8.4.3. Pharmaceutical Companies
8.4.4. Contract Research Organizations
8.4.5. Others
Chapter 9. Global Tissue Diagnostics Market, Regional Analysis
Related Report:
Cancer Diagnostics Market Size, Share & Forecast, 2019 – 2025
Cancer Diagnostics Market will exceed USD 170.0 billion by 2025, as per a new research report. Growing number of diagnostic as well as research laboratories coupled with rising awareness about early disease diagnosis will surge the demand for cancer diagnostics over the forecast timeline. Increasing healthcare spending, emerging healthcare infrastructure of developing countries and growing awareness about cancer will positively impact the industry growth.
Increasing number of people suffering from cancer will act as primary factor for driving cancer diagnostics market. According to the WHO, cancer is second leading cause of mortality in the world and responsible for around 9.6 million deaths globally in 2018. Unhealthy diet, tobacco and alcohol consumption along with physical inactivity are major causative factors for target disease. Thus, rising causative factors will escalate number of cancer cases thereby, stimulating the industry growth.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.